These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Imaging at higher magnetic fields: 3 T versus 1.5 T. Boll DT; Merkle EM Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):549-64, xi-xii. PubMed ID: 21094455 [TBL] [Abstract][Full Text] [Related]
4. MR imaging of the biliary system. Brink JA; Borrello JA Magn Reson Imaging Clin N Am; 1995 Feb; 3(1):143-60. PubMed ID: 7767742 [TBL] [Abstract][Full Text] [Related]
5. High spatial resolution, respiratory-gated, t1-weighted magnetic resonance imaging of the liver and the biliary tract during the hepatobiliary phase of gadoxetic Acid-enhanced magnetic resonance imaging. Lee ES; Lee JM; Yu MH; Shin CI; Woo HS; Joo I; Stemmer A; Han JK; Choi BI J Comput Assist Tomogr; 2014; 38(3):360-6. PubMed ID: 24681858 [TBL] [Abstract][Full Text] [Related]
7. MR imaging of the biliary system. Yam BL; Siegelman ES Radiol Clin North Am; 2014 Jul; 52(4):725-55. PubMed ID: 24889169 [TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of biliary tumors. Matos C; Serrao E; Bali MA Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):477-96, x. PubMed ID: 21094451 [TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary and pancreatic MRI and MRCP findings in patients with HIV infection. Bilgin M; Balci NC; Erdogan A; Momtahen AJ; Alkaade S; Rau WS AJR Am J Roentgenol; 2008 Jul; 191(1):228-32. PubMed ID: 18562750 [TBL] [Abstract][Full Text] [Related]
10. Iron-EHPG as an hepatobiliary MR contrast agent: initial imaging and biodistribution studies. Lauffer RB; Greif WL; Stark DD; Vincent AC; Saini S; Wedeen VJ; Brady TJ Int J Rad Appl Instrum B; 1988; 15(1):47-9. PubMed ID: 3350696 [No Abstract] [Full Text] [Related]
11. Gd-DISIDA--a potential contrast agent for magnetic resonance imaging of the hepatobiliary system. Saha GB; Bateson BP; Meaney TF; Ng TC; Go RT; MacIntyre WJ; Feiglin DH; O'Donnell JK J Nucl Med Allied Sci; 1989; 33(1):1-6. PubMed ID: 2746364 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the biliary tree and gallbladder with hepatocellular MR contrast agents. Gupta RT Curr Probl Diagn Radiol; 2013; 42(2):67-76. PubMed ID: 23332139 [TBL] [Abstract][Full Text] [Related]
13. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA. Yoshikawa K; Inoue Y; Akahane M; Shimada M; Itoh S; Seno A; Hayashi S J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333 [TBL] [Abstract][Full Text] [Related]
14. Hepatobiliary pathology. Taylor SL; Haque S Curr Opin Gastroenterol; 2011 May; 27(3):248-55. PubMed ID: 21423007 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance cholangiopancreatography. Mehta SN; Reinhold C; Barkun AN Gastrointest Endosc Clin N Am; 1997 Apr; 7(2):247-70. PubMed ID: 9101265 [TBL] [Abstract][Full Text] [Related]
16. Vascular and biliary variants in the liver: implications for liver surgery. Catalano OA; Singh AH; Uppot RN; Hahn PF; Ferrone CR; Sahani DV Radiographics; 2008; 28(2):359-78. PubMed ID: 18349445 [TBL] [Abstract][Full Text] [Related]
17. MR cholangiography. Hartman EM; Barish MA Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):841-55, vii. PubMed ID: 11694441 [TBL] [Abstract][Full Text] [Related]
18. [Imaging procedures in gastroenterology. Magnetic resonance tomography]. Loeffler W Verh Dtsch Ges Inn Med; 1988; 94():154-8. PubMed ID: 3206926 [No Abstract] [Full Text] [Related]